Navigation Links
Zinc Protoporphyrin (ZPP), Whole Blood Industrial

ProductsZinc Protoporphyrin (ZPP), Whole Blood Industrial
Company ARUP Laboratories
Item Zinc Protoporphyrin (ZPP), Whole Blood Industrial
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. Protoporphyrin, Fecal
2. Protoporphyrin, Free Erythrocyte (FEP)
3. Protoporphyrin, Zinc
4. Protoporphyrin, Zinc, Industrial
5. Zinc Protoporphyrin (ZPP), Whole Blood
6. Porphyrins, Whole Blood (ZPP), Industrial
7. Series 590 Low Cost Whole Blood Aggregometers
8. ACCUTEST Mononucleosis Whole Blood Test
9. ACCUTEST H. pylori Test (Whole Blood)
10. SST-1 Whole-field Scotopic Sensitivity Tester
11. Liquichek Whole Blood Volatiles Control
...uptures are problem enough for your patients. Now ...unctional treatment for foot and ankle fractures a...TORM. A combination of prefabricated brace and ope...nt with higher standards of safety. The storm can ...
The Active Ankle Trainer model provides medial/lateral support and optimum ankle mobility for chronic and prophylactic use.
The Bledsoe M-Brace Ankle Support reduces ankle swelling while boosting the patient's confidence when its time to get back in the game. The M-Brace is available in two models the Air M-Brace or the
The Bledsoe ST & ST2 Boots are low-cost, lightweight walkers for short term applications. The ST & ST2 are designed to enhance mobility for sprains, strains, and some types of fractures. The Bledsoe
Medicine Products:
(Date:11/21/2008)...N(Nov. 21, 2008)The University of Texas Health Sci...Training Excellence in Aging Studies (TEXAS), to p...a prestigious $2 million award from the Donald W. ...funds., "This will allow us to teach geriatric me... medical student to practicing physicians. With th...
(Date:11/21/2008)... Ariz., Nov. 21 The Prov...y announced that Craig A. Norris, the Company,s,C...Company,s Board of,Directors. Mr. Norris, appoin...signation of Steven I. Geringer and returns the bo... any committee of the Board. , Mr. Norris, ...
(Date:11/21/2008)...showed Banzel proved effective against Lennox-Gast...Day News) -- A new drug called Banzel (rufinamide)...r a severe form of epilepsy called Lennox-Gastaut ...nounced Friday. , The approval was based on res...patients ages 4 to 30. Compared to patients who to...
(Date:11/21/2008)...OWN, W.Va., Nov. 21 New...ng whether a smokeless, spitless tobacco product a...rchers have found that RJ Reynolds, Camel Snus - t...ction - contains surprisingly high levels of nicot... than most other snuff products," said Bruce Adkin...
Breaking Medicine News(10 mins):Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 2Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 4Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 3Health News:FDA Approves New Drug for Severe Epilepsy 2Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3
... adults to have their blood sugar, blood pressure,...n if they belong to a high-quality Medicare plan, ...shed in Wednesday's Journal of the American Medica... disparities are common throughout the Medicare sy...
...mistic about personalized medicine enabled through...e future.// Personalized medicine would not only i...se, ascertained by presence of the specific gene, ...strategies. The personalized genetic testing envi...
...cid every day could have better chance of getting ...form of vitamin B is used in our bodies to make ne...ody before she is pregnant, it can help prevent ma...'s brain and spine. However, the latest study invo...
...placement therapy could help people who want quit ...the Otto Wagner Hospital// in Vienna enrolled 68 s...ne-replacement therapy, reported the online editio...e time, half the would be quitters enrolled in an ...
Other Medicine News:Health News:Medicare Marked by Widespread Racial disparities 2Health News:Folic Acid Supplements Could Help Conception 2
(Date:11/20/2008)..., , , PHILADELPHIA, Nov. 20 /PRNewswire... announced that the United States Food and Drug Ad...r PROMACTA(R) (eltrombopag) for the treatment of t...diopathic) thrombocytopenic purpura (ITP) who have...immunoglobulins or splenectomy. The approval is a ...
(Date:11/20/2008)...DE, Calif., Nov. 20 Milk. It does ...an originally thought. After years of,research, s...tides found in,cow,s milk that stimulate the body... view the Multimedia News Release, go to:, http://... While developing new cancer therapies, the c...
(Date:11/20/2008)...GE, Mass., Nov. 20 Radius Health (...ditional $15 million to its second institutional f...nt to $82.5 million and the total amount raised si... existing institutional investors participated in ...d and including MPM Capital, The Wellcome Trust, H...
(Date:11/20/2008)...MSO, Norway, November 20 The Scand...harma has announced results of studies on its,lea...AAC in Washington, DC,the studies showed that th...acteriocidal effect, significantly better towards ...yogenes than marketed gold standard drugs. In,add...
Breaking Medicine Technology:FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8Photos: Peptides Discovered to Alleviate Chemotherapy Side Effects 2Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million 2Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2Rigel to Present at the Oppenheimer 19th Annual Healthcare Conference 28053 1Riverock Technologies Helps Misukanis 26amp 3B Odden Eliminate Task Management Obstacles 8684 1Riverock Technologies Helps Misukanis 26amp 3B Odden Eliminate Task Management Obstacles 8684 2Riverock Technologies Helps Misukanis 26amp 3B Odden Eliminate Task Management Obstacles 8684 3SkinMedica Hosts Aesthetics Division National Sales Meeting 28050 1SkinMedica Hosts Aesthetics Division National Sales Meeting 28050 2SkinMedica Hosts Aesthetics Division National Sales Meeting 28050 3No Difference in Rate of Survival for Children of Different Races Undergoing Liver Transplantation but Long Term Results Not as Good for African Amer 28048 1No Difference in Rate of Survival for Children of Different Races Undergoing Liver Transplantation but Long Term Results Not as Good for African Amer 28048 2No Difference in Rate of Survival for Children of Different Races Undergoing Liver Transplantation but Long Term Results Not as Good for African Amer 28048 3
...25, 2007 - GTx, Inc., (NASDAQ:,GTXI) announced tod...cept clinical trial of Ostarine(TM) and from the o...NE(R) (toremifene citrate) 80,mg for the treatment...therapy (ADT) will be presented at the upcoming 20...cal Oncology being,held June 1 - 5 at McCormick Pl...
...y 24, 2007 - A new analysis,has found that many al...inadvertently omit women and African-Americans fro... Medicine,researcher who led the effort said the f...tudy eligibility criteria can have,unintended, neg... of 100,000 alcohol treatment,patients, Keith Hump...
Other Medicine Technology:GTx Announces Presentation of Ostarine and Acapodene Data at 2007,ASCO Annual Meeting 2GTx Announces Presentation of Ostarine and Acapodene Data at 2007,ASCO Annual Meeting 3Limiting Eligibility for Medical Studies Can Omit Women,African-Americans, Stanford Study Finds 2Limiting Eligibility for Medical Studies Can Omit Women,African-Americans, Stanford Study Finds 3